SCHEMBL23215825

SCHEMBL23215825

Br[Zn]Br.[CH2]C(=O)OCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
TSHR P16473 5/20 0.50
HPGD P15428 1/20 0.50
ATM Q13315 1/20 0.48
HCAR2 Q8TDS4 1/20 0.42
NAAA Q02083 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
ESR1 P03372 2/20 0.40
EPHX1 P07099 1/20 0.39
FAAH O00519 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
NR1H2 P55055 1/20 0.39
RNASEL Q05823 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50459 0.91
SCHEMBL232653 0.84
SCHEMBL4363618 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL4653423 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL8356788 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL8915954 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL3034401 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL8893832 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL5733798 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA
SCHEMBL3015647 0.82 NAAA (0.61) ALDH1A1TSHRHCAR2NAAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230061736-A1 GPR119 AGONISTS KALLYOPE, INC. 2023-03-02 US disclosed
US-20220153719-A1 GPR119 AGONISTS KALLYOPE, INC. 2022-05-19 US disclosed
WO-2021071837-A1 GPR119 AGONISTS KALLYOPE, INC. (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230061736-A1 GPR119 AGONISTS GPR119, GLP1R, GCGR ALDH1A1 1523/4885TSHR 472/4885HPGD 1594/4885
US-20220153719-A1 GPR119 AGONISTS GPR119, GLP1R, GCGR ALDH1A1 1523/4885TSHR 472/4885HPGD 1594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.